From Raw Material to Finished Ingredient: How Liposomal Vitamin C Powder Is Developed

A liposomal vitamin C powder project rarely fails on payload. It fails on colour. A batch that assays on target at release and then moves from light yellow toward amber in storage has already told you where the development work went wrong: the ascorbate sitting in the aqueous core was oxidising while the certificate still read clean. This article follows that reaction through the process, using the liposomal vitamin C powder range from EmerWell as the reference — 10%, 20%, 25% and 50% grades, encapsulation efficiency of 85%–95%, Pb below 0.5 ppm and total plate count under 1,000 cfu/g.

The Loss Map: Where Ascorbate Is Lost, and What Shows It First

L-ascorbic acid is defined by being a reducing agent, and that single property is the source of every handling difficulty that follows. It gives up electrons to oxygen readily. The first product, dehydroascorbic acid, is still a lactone, but the ring opens to 2,3-diketogulonic acid, and the fragments beyond that polymerise into yellow-brown pigments. None of this requires a mistake in the plant. It requires water, oxygen, heat and time, and a liposome slurry supplies all four at once.

The second route is catalytic. Trace iron and copper accelerate the same reaction at concentrations well below any declared specification limit, and a metal does not have to be an ingredient to be present: it arrives with lecithin, with buffer salts, with process water, and from the wetted surfaces of pumps and homogeniser valves. Chelation with citrate is the usual answer where a clean label rules out synthetic chelators, and it is a partial answer at best.

The third route is thermal and photochemical. Heat raises the rate of every step above; ultraviolet and short-wavelength visible light drive the same conversion at the surface of a powder or a thin film. A drying operation that looks gentle on a temperature chart can still deliver a large cumulative heat dose to a concentrate that has almost no water left to buffer it.

Loss route	Where the process creates it	Earliest observable signal	Lever that acts on it
Oxidation to dehydroascorbic acid	Dissolved oxygen in the aqueous phase, warm hold before drying	Iodometric titre falling ahead of HPLC total	Nitrogen sparge, short hold times
Metal-catalysed decomposition	Iron or copper from lecithin, water, valve wear	Colour drift while assay is still in band	Citrate chelation, loop flushing, source control
Ring opening to diketogulonic acid	Bulk heat during homogenisation and drying	pH drift in the reconstituted dispersion	Chilled feed, capped residence time
Photodegradation	Open transfers, clear packaging	Uneven surface discolouration	Shielded transfer, opaque pack

Why Aqueous Core Loading Is a Different Engineering Problem

A fat-soluble active partitions into the bilayer and stays because the bilayer is the phase it prefers. A water-soluble one has no such preference. It is encapsulated because it was dissolved in the water that became the core, and it stays only while the bilayer remains intact. Encapsulation efficiency is therefore governed by trapped volume and by how completely the external phase is removed, not by an equilibrium that draws the molecule back in. It is also why the delivery system has to be judged after separation, never on the unseparated slurry.

Charge complicates the picture. Ascorbic acid has pKa values near 4.1 and 11.6. Below the first, most of the molecule is uncharged and crosses a phospholipid bilayer comparatively quickly; above it, the monoanion is retained far better but is also the species that reacts with oxygen and with transition metals. A low pH slows oxidation in the bulk and at the same time accelerates ester hydrolysis of the phosphatidylcholine, so the working window is a compromise chosen per formulation rather than a number copied from a textbook. The chemistry behind that trade-off is set out in this note on vitamin C stability in aqueous systems.

Control Point One: The Aqueous Phase Itself

The aqueous phase is where the oxidation clock starts, and it should be run as a formulated intermediate, not as water with powder dissolved in it. pH is the first decision: set it before hydration, measure it at the temperature of use, and confirm it again after homogenisation, because a shift of a few tenths across the process is common and it alters both retention and reaction rate. Citrate buffers and chelates in the same molecule, which is why it appears in so many of these systems.

Ionic strength is the parameter most often left undefined. Salt screens the surface charge that keeps vesicles apart, so a high-salt aqueous phase produces aggregation during hydration that later reads as a bimodal size distribution. The practical rule is to use the lowest ionic strength that holds the pH, and to write that value into the batch record rather than leaving it to the operator. Dissolved oxygen belongs to the same control point: a nitrogen sparge before hydration and a short hold remove a large share of the catalytic load for very little cost.

Control Point Two: Hydration and the Water-to-Lipid Ratio

Hydration converts a dry lipid film or powder into lamellar vesicles with an aqueous core. The ratio of water to lipid fixes how much ascorbate each vesicle can carry and how viscous the dispersion becomes. Too little water gives incomplete hydration and a heterogeneous population of multilamellar structures; too much dilutes the payload, adds dissolved oxygen and lengthens thermal exposure at drying, because every litre of water must later be removed.

Hydration temperature should sit above the transition of the phospholipid so the bilayer is fluid; hydration below it produces layered structures that resist size reduction. A dispersion still showing visible lipid flakes at this stage will not be rescued by the homogeniser, and the resulting particle size distribution will be broad in a way that later reads as a process failure rather than a raw material one.

Control Point Three: Homogenisation Temperature and Residence Time

Size reduction is where two requirements collide. The energy needed to break multilamellar vesicles into small unilamellar ones is delivered as pressure and partly converted to heat, and the reaction rate of ascorbate with oxygen roughly doubles for every ten degrees of temperature rise. Chilling the feed and the homogeniser head, then holding bulk temperature below the point where that rate climbs steeply, does more for colour stability than any additive added downstream. The surrounding unit operations are covered in this review of manufacturing standards for this grade.

Residence time is the second half of the same control point and is usually under-recorded. Oxidation accumulates over the whole sequence, from the moment of hydration through recirculation passes, transfer lines and any hold tank before drying, not only during the pass through the valve. A three-pass process on a short loop can expose the dispersion for less time than one pass on a long loop. Record cumulative minutes at temperature, not pass count.

Control Point Four: Drying

Drying is the step most often described as protective and least often controlled for oxidation. In spray drying the inlet temperature is not the temperature the solids experience; evaporative cooling holds particle temperature well below it while water is present. The exposure that matters comes later in the trajectory, when the droplet has become a concentrated ascorbate solution with a high metal-to-water ratio and the last moisture is being driven off. The trade-offs between drying routes are mostly decided here.

Freeze drying removes heat from the problem and adds two of its own. Freezing concentrates solutes in the unfrozen phase, and that concentrate is reactive; the cake that results is also open and hygroscopic, so it takes up moisture and oxygen quickly once the vacuum is released. Either way the powder attributes buyers test are set at this step: cold-water dispersibility with no layer separation on standing, bulk flow, and moisture low enough to keep the matrix glassy.

Packaging closes the sequence. A foil laminate with a desiccant, nitrogen-flushed and opaque, extends everything the dryer achieved; a clear jar undoes it. The handling points that matter after release are summarised in this guidance on storage conditions for the bulk powder.

Colour as a Process Signal

Browning is the most sensitive instrument in the whole process, and it is usually filed as a cosmetic attribute. Pigment formation begins while ascorbate loss is still inside assay variability, so a colour measurement detects the reaction before a content test does. Reading L* and b* against a retained reference standard, on a fixed sample preparation and a fixed instrument, turns appearance into a trend rather than an argument at release.

Release Testing and the Oxidation Index

A single ascorbate assay cannot tell you whether a low result came from raw material or from the process. Two measurements can. Iodometric titration reports reducing ascorbate; a stability-indicating HPLC method reports total ascorbate, and the gap between them is the oxidised fraction. Read together with colour, the pair separates a batch made from partly degraded raw material from one that degraded during homogenisation or drying — the difference between a supplier claim and a process investigation. The tests used at release are worth agreeing in writing before the first batch.

Release item	Method	Result expected for this grade
Ascorbate content	HPLC	Within the declared load, 10% to 50%
Reducing ascorbate	Iodometric titration	Consistent with the HPLC total
Encapsulation efficiency	Separation, then HPLC on both fractions	85%–95%
Particle size	DLS, intensity distribution	Single population on rehydration
Morphology	TEM	Intact bilayers, no crystalline debris
Colour	L* and b* against retained standard	Inside the agreed bracket
Lead	Elemental analysis	Below 0.5 ppm
Total plate count	Compendial plate count	Under 1,000 cfu/g

The Three Parameters That Drift First at Scale

The first is bulk temperature in the loop. Heat removal scales with surface area while heat generation scales with volume, so a production batch runs warmer than the pilot batch at identical settings unless the jacket is cooled to compensate. The pilot record is not the instruction; the measured bulk temperature is.

The second is cumulative residence time. Longer transfer lines, larger hold tanks and slower downstream equipment all add minutes at temperature. A scale-up that preserves pressure and pass count but doubles the time between hydration and drying will produce a darker powder from the same nominal process, and the drift will look like a raw material problem unless the batch record carries time at temperature.

The third is water activity at the dryer outlet, which shifts as throughput rises and chamber residence time falls. Moisture that was acceptable at pilot scale becomes a caking and browning problem at production scale. Trending outlet moisture and colour together, batch over batch, exposes the drift before a customer does — and before a stability study confirms it, as the note on shelf-life data for this powder explains.

Working With EmerWell on a Vitamin C Programme

EmerWell supplies this ingredient at 10%, 20%, 25% and 50% from a cGMP facility operating to ISO 9001:2015 and ISO 22000, with Kosher and Halal certification, and with Gluten-Free, Non-GMO, Vegan-friendly and Soy-Free options. Release data covers HPLC, DLS, TEM and iodometric results, with Pb below 0.5 ppm and total plate count under 1,000 cfu/g. To check those certifications against your own market requirements, or to discuss a pH window, drying route and colour limit for your format, request a certificate of analysis and a sample from the liposomal vitamin C powder page, or write to info@emerwell-bio.com.

References

1. U.S. Food and Drug Administration. 21 CFR Part 111 — Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. ecfr.gov

2. U.S. Food and Drug Administration. 21 CFR Part 117 — Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food. ecfr.gov

3. European Food Safety Authority. Health claims — regulatory framework and evaluations. efsa.europa.eu

4. National Center for Biotechnology Information. PubChem Compound Summary: Ascorbic Acid. pubchem.ncbi.nlm.nih.gov

This article is written for formulators, quality teams and procurement staff evaluating a bulk ingredient. It is not medical or nutritional advice, and it makes no claim about the use of any finished product.